Levels of neuropeptide-Y in the plasma and skin tissue fluids of patients with vitiligo

Journal of Dermatological Science

Volumn 27, Issue 3, 2001, Pages 178-182

  Tu, Caixia ^a   Zhao, Daming ^a   Lin, Xiran ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Neuropeptide Y; Plasma; Skin tissue fluid; Vitiligo

Indexed keywords

IODINE 125; NEUROPEPTIDE Y;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; MALE; MELANOCYTE; NEUROIMMUNOLOGY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; SCHOOL CHILD; SKIN; SKIN DEFECT; TISSUE LEVEL; TISSUE WATER; VITILIGO;

ADOLESCENT; ADULT; AGED; BLOOD; BODY FLUIDS; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPEPTIDE Y; SKIN; VITILIGO;

EID: 0034788784     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(01)00134-7     Document Type: Article

References (18)

1. Life without neuropeptide Y
2. Neuropeptides in skin
3. Neuro-immuno-cutaneous system (NICS)
4. Neuropeptide and neuronal marker studies in vitiligo
5. Markers for vitiligo related neuropeptides in human skin nerve fibers
6. Vitiligo: Clinical findings in 1436 patients
7. Vitiligo-related neuropeptides in nerve fibers of the skin
8. Modulation of immune cell function by the autonomic nervous system
9. Neuropeptides, by direct interaction with T cells, induce cytokine secretion and break the commitment to a distinct T helper phenotype (T helper cells 1 and 2)
10. Further evidence for involvement of both cell mediated and humoral immunity in generalized vitiligo
11. Innervation of melanocytes in human skin
12. Differential effects of gastrin-releasing peptide, neuropeptide Y, somatostatin and vasoactive intestinal peptide on interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha production by whole blood cells from healthy young and old subjects
13. Growth control of melanoma cells and melanocytes by cytokines
14. Relationship between levels of soluble interleukin-2 receptors and the types and activity of vitiligo
15. Levels of soluble interleukin-2 receptor in the sera and skin tissue fluids of patients with vitiligo
16. Morphologic observations on the dermal nerves in vitiligo: An ultrastructural study
17. Neuropeptides in dermatologic therapy
18. New approaches in the pharmacological treatment of obesity